Patient-related variables |
|
|
|
|
|
|
|
|
Age |
per year |
0.99 |
|
|
|
|
|
|
DBP at initial diagnosis of hypertension |
per mmHg |
|
1.03 |
1.06 |
|
|
|
1.02 |
Controlled DBP at baseline |
if present |
|
|
|
|
|
|
0.20 |
Uncontrolled DBP at baseline |
if present |
|
|
|
|
4.72 |
|
|
Diabetes |
if present |
20.53 |
15.85 |
19.77 |
20.33 |
13.57 |
|
|
Obesity |
if present |
|
|
1.42 |
|
|
|
|
Highly vulnerable to uncontrolled hypertension cluster |
if present |
1.65 |
|
|
|
|
|
|
Total cardiovascular risk: moderate added risk |
if present |
|
|
|
|
|
8.25 |
|
Total cardiovascular risk: high added risk |
if present |
|
|
|
|
|
43.75 |
2.85 |
Total cardiovascular risk: very high added risk |
if present |
|
|
|
|
|
39.44 |
|
Conditions and risk factors: no pre-existing |
if no pre-existing |
|
|
|
|
|
|
0.46 |
Conditions and risk factors: diabetes |
present |
|
|
|
|
|
|
1.62 |
Concomitant antihypertensive treatment: ACE inhibitor |
if present |
(1.98) |
|
0.45 |
|
|
|
|
Concomitant antihypertensive treatment: alfa blocker |
if present |
|
|
|
(3.76) |
|
|
|
Concomitant antihypertensive treatment: diuretic |
if present |
|
|
|
(3.11) |
|
|
|
Patient-reported nonadherence behavior |
if reported |
|
1.59 |
|
|
|
|
|
Physician-rated adherence |
per point (0–100 scale) |
|
|
0.98 |
0.97 |
|
|
0.98 |
Physician-related variables |
|
|
|
|
|
|
|
|
Years since medical school graduation (in practice) |
per year |
|
|
|
1.05 |
|
|
|
Hypertensive patients seen in past 12 months |
per patient |
0.99 |
|
|
|
|
|
|
Visits typically scheduled by physician with newly diagnosed hypertension patient in first 3 months |
per visit |
0.98 |
|
|
|
|
|
|
Self-reported practices consistent with evidence-based guidelines re: DBP threshold for treatment initiation |
per practice (0–6) |
0.81 |
|
|
|
0.87 |
|
|
Self-reported practices consistent with evidence-based guidelines re: DBP threshold for treatment intensification |
per practice (0–6) |
|
0.82 |
|
|
|
|
|
Continuing education on hypertension in past 12 months |
present |
|
(1.36) |
|
|
|
|
|